PAPER Chang LK, Zhao JH, Liu HL, Wu JW, Chuang CK, Liu KT, Chen JT, Tsai WB, Ho Y
SEARCH RESULTS
331008 RESULTS
PAPER
Biomarkers may help predict risk of Alzheimer's disease.
J Inherit Metab Dis. 2010 Jun 8; PubMed: 20477523PAPER Ereshefsky L, Jhee S, Yen M, Moran S, Pretorius S, Adams J
Cerebrospinal fluid beta-amyloid and dynabridging in Alzheimer's disease drug development.
Biomark Med. 2009 Dec;3(6):711-21. PubMed: 20477709PAPER Mattsson N, Zetterberg H
Alzheimer's disease and CSF biomarkers: key challenges for broad clinical applications.
Biomark Med. 2009 Dec;3(6):735-7. PubMed: 20477711PAPER Juréus A, Swahn BM, Sandell J, Jeppsson F, Johnson AE, Johnström P, Neelissen JA, Sunnemark D, Farde L, Svensson SP
Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand.
J Neurochem. 2010 Aug;114(3):784-94. PubMed: 20477945PAPER Hughes M, Snetkov V, Rose RS, Trousil S, Mermoud JE, Dingwall C
Neurite-like structures induced by mevalonate pathway blockade are due to the stability of cell adhesion foci and are enhanced by the presence of APP.
J Neurochem. 2010 Aug;114(3):832-42. PubMed: 20477946PAPER Yu C, Nwabuisi-Heath E, Laxton K, LaDu MJ
Endocytic pathways mediating oligomeric Abeta42 neurotoxicity.
Mol Neurodegener. 2010;5:19. PubMed: 20478062PAPER Fang CL, Wu WH, Liu Q, Sun X, Ma Y, Zhao YF, Li YM
Dual functions of beta-amyloid oligomer and fibril in Cu(II)-induced H2O2 production.
Regul Pept. 2010 Aug 9;163(1-3):1-6. PubMed: 20478342PAPER Seppälä TT, Herukka SK, Hänninen T, Tervo S, Hallikainen M, Soininen H, Pirttilä T
Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study.
J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1123-7. PubMed: 20478847PAPER Sureshbabu N, Kirubagaran R, Thangarajah H, Malar EJ, Jayakumar R
Lipid-induced conformational transition of amyloid beta peptide fragments.
J Mol Neurosci. 2010 Jul;41(3):368-82. PubMed: 20480256PAPER Novelli MM, Nitrini R, Caramelli P
Validation of the Brazilian version of the quality of life scale for patients with Alzheimer's disease and their caregivers (QOL-AD).
Aging Ment Health. 2010 Jul;14(5):624-31. PubMed: 20480421PAPER Saraiva AM, Cardoso I, Saraiva MJ, Tauer K, Pereira MC, Coelho MA, Möhwald H, Brezesinski G
Randomization of amyloid-β-peptide(1-42) conformation by sulfonated and sulfated nanoparticles reduces aggregation and cytotoxicity.
Macromol Biosci. 2010 Oct 8;10(10):1152-63. PubMed: 20480510PAPER Wolk DA, Dickerson BC,
Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.
Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10256-61. PubMed: 20479234PAPER Grune T, Botzen D, Engels M, Voss P, Kaiser B, Jung T, Grimm S, Ermak G, Davies KJ
Tau protein degradation is catalyzed by the ATP/ubiquitin-independent 20S proteasome under normal cell conditions.
Arch Biochem Biophys. 2010 Aug 15;500(2):181-8. PubMed: 20478262PAPER Onofrj M, Bonanni L, Manzoli L, Thomas A
Cohort study on somatoform disorders in Parkinson disease and dementia with Lewy bodies.
Neurology. 2010 May 18;74(20):1598-606. PubMed: 20479358Current Filters
No filters selected